Kennon McCollum explains how psychosocial, physical, and financial barriers impact treatment selection for patients with CLL.
Kennon McCollum, DNP
Advertisement
Articles by Kennon McCollum, DNP
Kennon McCollum, DNP, explains how multiday ES-SCLC chemotherapy regimens heighten myelosuppression risk and drive dose delays.
Advertisement
Latest Updated Articles
Chemo-Induced Myelosuppression Presentation and Management in ES-SCLCNovember 22nd 2025
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
2
Addressing Financial Toxicity: Team-Based Workflows in Oncology Care
3
Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses
4
SBRT Reduces Bowel Toxicity in Localized Intermediate-Risk Prostate Cancer
5